Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
- B6032 CB-5083Target: p97Summary: p97 inhibitor
- B2151 STF-62247Target: AutophagySummary: Autophagy inducer in renal cell
- A8198 P 22077Summary: USP7/(DUB)USP47 inhibitor
- A3023 P0050911 CitationTarget: Ubiquitin-specific proteasesSummary: Ubiquitin-specific protease 7 (USP7) inhibitor
- A4002 IU1Summary: Usp14 inhibitor
- A4003 LDN 57444Target: UCHSummary: UCH-L1 inhibitor,reversible competitve
- A4004 NSC 632839 hydrochlorideSummary: Isopeptidases inhibitor
- A4007 MLN97083 CitationTarget: ProteasomeSummary: Proteasome inhibitor
- A2601 Aclacinomycin ATarget: TopoisomerasesSummary: Topoisomerase I and II inhibitor
- A2604 CelastrolTarget: ProteasomeSummary: Antioxidant, anti-inflammatory and immunosuppressive agent